Novartis posted stronger Q2 sales, helped by robust demand for its blockbuster medicines. The Swiss drugmaker also maintained its full-year 2026 outlook.
Intas Pharmaceuticals has achieved a major milestone in India's breast cancer drug market. The company has received CDSCO approval to market its Trastuzumab Emtansine biosimilar in India.
A new Weekly HIV Pill could change how people manage HIV. Gilead Sciences and Merck reported positive results from two late-stage studies.
A fresh Trump tariff warning dragged pharma stocks lower on Tuesday. Investors turned cautious after Donald Trump proposed steep duties on imported generic drugs.
Trump’s new tariff plan has raised fresh concerns for Indian pharma companies that depend on the US market. US President Donald Trump announced a phased tariff policy for imported generic drugs.
International researchers have raised fresh concerns over papaya cancer research conducted by Tata Memorial Centre. They have questioned whether the study provides enough evidence to support its conclusions.
Gujarat has intensified its health surveillance after Chandipura virus infected 12 people across the state. The development prompted Health Minister Praful Pansheriya to review the situation with senior officials.
Fatty Pancreas is no longer considered a harmless finding on medical scans. A global Expert Consensus has now recognized it as a disease.
A Rare Brain Disorder linked to Measles is now under the spotlight as a Hyderabad-based institute launches a new Research Study.
Poviztra Approval has marked a major step for fatty liver treatment in India. Emcure Pharmaceuticals has received CDSCO approval to market Poviztra for eligible adults with MASH.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")